Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TMPRSS2 Is Essential for SARS-CoV-2 Beta and Omicron Infection
Kristin Metzdorf, Henning Jacobsen, Marina C. Greweling‐Pils, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 271-271
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

SARS-CoV-2 Omicron entry is type II transmembrane serine protease-mediated in human airway and intestinal organoid models
Anna Z. Mykytyn, Tim I. Breugem, Maarten H. Geurts, et al.
Journal of Virology (2023) Vol. 97, Iss. 8
Open Access | Times Cited: 27
Precision nutrition to reset virus-induced human metabolic reprogramming and dysregulation (HMRD) in long-COVID
A. Satyanarayan Naidu, Chin‐Kun Wang, Pingfan Rao, et al.
npj Science of Food (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 8
Computational screening combined with well-tempered metadynamics simulations identifies potential TMPRSS2 inhibitors
C. S. Sharanya, D. Sasikala Wilbee, Shijulal Nelson‐Sathi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Recent Advances on Targeting Proteases for Antiviral Development
Pedro Henrique Oliveira Borges, Sabrina Baptista Ferreira, Floriano Paes Silva
Viruses (2024) Vol. 16, Iss. 3, pp. 366-366
Open Access | Times Cited: 5
ACE2 acts as a novel regulator of TMPRSS2-catalyzed proteolytic activation of influenza A virus in airway cells
Miriam Ruth Heindl, Anna-Lena Rupp, Marie Schwerdtner, et al.
Journal of Virology (2024) Vol. 98, Iss. 4
Open Access | Times Cited: 5
Subsequent Waves of Convergent Evolution in SARS-CoV-2 Genes and Proteins
Daniele Focosi, Pietro Giorgio Spezia, Fabrizio Maggi
Vaccines (2024) Vol. 12, Iss. 8, pp. 887-887
Open Access | Times Cited: 5
Dissecting the Binding Affinity of Anti-SARS-CoV-2 Compounds to Human Transmembrane Protease, Serine 2: A Computational Study
Yongwei Shi, Jianxin Shen, Tao Yan, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 587-587
Open Access
Trypstatin as a Novel TMPRSS2 Inhibitor with Broad-Spectrum Efficacy Against Corona and Influenza Viruses
Jan Lawrenz, Lukas Wettstein, Armando Rodríguez, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Variants of SARS-CoV-2: Influences on the Vaccines’ Effectiveness and Possible Strategies to Overcome Their Consequences
Ali A. Rabaan, Shamsah H. Al-Ahmed, Hawra Albayat, et al.
Medicina (2023) Vol. 59, Iss. 3, pp. 507-507
Open Access | Times Cited: 13
Influence of Th1 versus Th2 immune bias on viral, pathological, and immunological dynamics in SARS-CoV-2 variant-infected human ACE2 knock-in mice
Shailendra Kumar Verma, Fernanda Ana‐Sosa‐Batiz, Julia Timis, et al.
EBioMedicine (2024) Vol. 108, pp. 105361-105361
Open Access | Times Cited: 4
DON/DRP‐104 as potent serine protease inhibitors implicated in SARS‐CoV‐2 infection: Comparative binding modes with human TMPRSS2 and novel therapeutic approach
Ernest Oduro‐Kwateng, Mahmoud E. S. Soliman
Journal of Cellular Biochemistry (2024)
Open Access | Times Cited: 3
ACE2-independent sarbecovirus cell entry is supported by TMPRSS2-related enzymes and reduces sensitivity to antibody-mediated neutralization
Lu Zhang, Hsiu-Hsin Cheng, Nadine Krüger, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Modelling the viral dynamics of the SARS-CoV-2 Delta and Omicron variants in different cell types
Clare P. McCormack, Ada W. C. Yan, Jonathan C. Brown, et al.
Journal of The Royal Society Interface (2023) Vol. 20, Iss. 205
Open Access | Times Cited: 9
Targeting Viral and Cellular Cysteine Proteases for Treatment of New Variants of SARS-CoV-2
Davide Gentile, Lucia Chiummiento, Alessandro Santarsiere, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 338-338
Open Access | Times Cited: 2
Advances in the understanding of androgen receptor structure and function and in the development of next-generation AR-targeted therapeutics
Wendy Effah, Marjana Khalil, Dong‐Jin Hwang, et al.
Steroids (2024) Vol. 210, pp. 109486-109486
Closed Access | Times Cited: 2
TMPRSS2 activation of Omicron lineage Spike glycoprotein is regulated by Collectrin-like domain of ACE2
Anupriya Aggarwal, Christina Fichter, Vanessa Milogiannakis, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 7
Impact of mutations defining SARS-CoV-2 Omicron subvariants BA.2.12.1 and BA.4/5 on Spike function and neutralization
Chiara Pastorio, Sabrina Noettger, Rayhane Nchioua, et al.
iScience (2023) Vol. 26, Iss. 11, pp. 108299-108299
Open Access | Times Cited: 7
Systematical assessment of the impact of single spike mutations of SARS-CoV-2 Omicron sub-variants on the neutralization capacity of post-vaccination sera
Maeva Katzmarzyk, Denise Christine Clesle, Joop van den Heuvel, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
One for all—human kidney Caki-1 cells are highly susceptible to infection with corona- and other respiratory viruses
Alison Daniels, Sarah Fletcher, H. Kerr, et al.
Journal of Virology (2023) Vol. 97, Iss. 9
Open Access | Times Cited: 5
Ancestral, Delta, and Omicron (BA.1) SARS-CoV-2 strains are dependent on serine proteases for entry throughout the human respiratory tract
Matthew J. Gartner, Leo Lee, Francesca L. Mordant, et al.
Med (2023) Vol. 4, Iss. 12, pp. 944-955.e7
Open Access | Times Cited: 5
Design, synthesis and biological evaluation of novel 1,2,4a,5-tetrahydro-4H-benzo[b][1,4]oxazino[4,3-d][1,4]oxazine-based AAK1 inhibitors with anti-viral property against SARS-CoV-2
Nian‐Dong Mao, Yueying Xu, Hao Che, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116232-116232
Closed Access | Times Cited: 1
Recent advances in application of computer-aided drug design in anti-COVID-19 Virials Drug Discovery
Weiying Yang, Ye Wang, Dongfeng Han, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116423-116423
Open Access | Times Cited: 1
Establishment, optimization and validation of a fluorescence polarization-based high-throughput screening assay targeting cathepsin L inhibitors
Wenwen Zhou, Baoqing You, Xiaomeng Zhao, et al.
SLAS DISCOVERY (2024) Vol. 29, Iss. 3, pp. 100153-100153
Open Access | Times Cited: 1
The host protease KLK5 primes and activates spike proteins to promote human betacoronavirus replication and lung inflammation
Hyunjoon Kim, Yeong-Lim Kang, Se‐Mi Kim, et al.
Science Signaling (2024) Vol. 17, Iss. 850
Closed Access | Times Cited: 1
ACE2-independent sarbecovirus cell entry can be supported by TMPRSS2-related enzymes and can reduce sensitivity to antibody-mediated neutralization
Lu Zhang, Hsiu-Hsin Cheng, Nadine Krüger, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 11, pp. e1012653-e1012653
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top